240 related articles for article (PubMed ID: 21586552)
1. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.
Kulak J; Fischer C; Komm B; Taylor HS
Endocrinology; 2011 Aug; 152(8):3226-32. PubMed ID: 21586552
[TBL] [Abstract][Full Text] [Related]
2. [Effect of bazedoxifene on endometriosis in a rat model].
Lyu H; Liu Y; Dang Q; Chen H; Chen R
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):291-5. PubMed ID: 26080942
[TBL] [Abstract][Full Text] [Related]
3. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
Naqvi H; Sakr S; Presti T; Krikun G; Komm B; Taylor HS
Biol Reprod; 2014 Jun; 90(6):121. PubMed ID: 24740602
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.
Sakr S; Naqvi H; Komm B; Taylor HS
Endocrinology; 2014 Apr; 155(4):1489-97. PubMed ID: 24484171
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
Jover-Mengual T; Castelló-Ruiz M; Burguete MC; Jorques M; López-Morales MA; Aliena-Valero A; Jurado-Rodríguez A; Pérez S; Centeno JM; Miranda FJ; Alborch E; Torregrosa G; Salom JB
J Steroid Biochem Mol Biol; 2017 Jul; 171():296-304. PubMed ID: 28479229
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study.
Palacios S; de Villiers TJ; Nardone Fde C; Levine AB; Williams R; Hines T; Mirkin S; Chines AA;
Maturitas; 2013 Sep; 76(1):81-7. PubMed ID: 23871271
[TBL] [Abstract][Full Text] [Related]
8. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
9. Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.
Flannery CA; Fleming AG; Choe GH; Naqvi H; Zhang M; Sharma A; Taylor HS
Endocrinology; 2016 Oct; 157(10):3699-3708. PubMed ID: 27267714
[TBL] [Abstract][Full Text] [Related]
10. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
Barrera J; Chambliss KL; Ahmed M; Tanigaki K; Thompson B; McDonald JG; Mineo C; Shaul PW
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E345-54. PubMed ID: 24939737
[TBL] [Abstract][Full Text] [Related]
11. [Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
Calaf Alsina J; Coronado Martín PJ
Med Clin (Barc); 2013 Mar; 140(6):266-71. PubMed ID: 23276611
[TBL] [Abstract][Full Text] [Related]
12. The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.
Lewis-Wambi JS; Kim H; Curpan R; Grigg R; Sarker MA; Jordan VC
Mol Pharmacol; 2011 Oct; 80(4):610-20. PubMed ID: 21737572
[TBL] [Abstract][Full Text] [Related]
13. Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.
Song Y; Santen RJ; Wang JP; Yue W
Endocrinology; 2012 Dec; 153(12):5706-15. PubMed ID: 23070546
[TBL] [Abstract][Full Text] [Related]
14. Tissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells.
Kulak J; Ferriani RA; Komm BS; Taylor HS
Reprod Sci; 2013 Feb; 20(2):129-37. PubMed ID: 23171676
[TBL] [Abstract][Full Text] [Related]
15. Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.
Pickar JH; Yeh IT; Bachmann G; Speroff L
Fertil Steril; 2009 Sep; 92(3):1018-1024. PubMed ID: 19635613
[TBL] [Abstract][Full Text] [Related]
16. Bazedoxifene-Conjugated Estrogens for Treating Endometriosis.
Flores VA; Stachenfeld NS; Taylor HS
Obstet Gynecol; 2018 Aug; 132(2):475-477. PubMed ID: 29995747
[TBL] [Abstract][Full Text] [Related]
17. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
Pickar JH; Mirkin S
Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
[TBL] [Abstract][Full Text] [Related]
18. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
[TBL] [Abstract][Full Text] [Related]
19. Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.
Berrodin TJ; Chang KC; Komm BS; Freedman LP; Nagpal S
Mol Endocrinol; 2009 Jan; 23(1):74-85. PubMed ID: 19036900
[TBL] [Abstract][Full Text] [Related]
20. Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats.
Maekawa H; Tada Y; Yagi K; Miyamoto T; Kitazato KT; Korai M; Satomi J; Hashimoto T; Nagahiro S
J Neuroinflammation; 2017 Oct; 14(1):197. PubMed ID: 28969701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
